Oscar Health (NYSE:OSCR) Trading Down 5.5% – Should You Sell?

by · The Markets Daily

Oscar Health, Inc. (NYSE:OSCR – Get Free Report) dropped 5.5% during mid-day trading on Wednesday . The company traded as low as $16.17 and last traded at $16.0350. Approximately 2,684,147 shares changed hands during trading, a decline of 81% from the average daily volume of 14,427,112 shares. The stock had previously closed at $16.96.

Analyst Ratings Changes

Several equities analysts recently issued reports on OSCR shares. Zacks Research upgraded Oscar Health from a “strong sell” rating to a “hold” rating in a research report on Monday, October 13th. Weiss Ratings restated a “sell (d)” rating on shares of Oscar Health in a research note on Wednesday, October 8th. Barclays increased their price target on Oscar Health from $11.00 to $13.00 and gave the stock an “underweight” rating in a report on Monday, November 10th. Piper Sandler raised shares of Oscar Health from a “neutral” rating to an “overweight” rating and boosted their price objective for the company from $13.00 to $25.00 in a research note on Tuesday, November 25th. Finally, Wall Street Zen cut shares of Oscar Health from a “hold” rating to a “sell” rating in a research note on Saturday. One equities research analyst has rated the stock with a Buy rating, five have given a Hold rating and four have issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Reduce” and a consensus target price of $15.33.

Check Out Our Latest Report on OSCR

Oscar Health Stock Performance

The stock’s 50 day moving average price is $17.94 and its two-hundred day moving average price is $16.99. The company has a current ratio of 0.92, a quick ratio of 0.92 and a debt-to-equity ratio of 0.67. The firm has a market capitalization of $4.19 billion, a price-to-earnings ratio of -14.29 and a beta of 1.88.

Oscar Health (NYSE:OSCR – Get Free Report) last issued its earnings results on Thursday, November 6th. The company reported ($0.53) earnings per share for the quarter, topping the consensus estimate of ($0.55) by $0.02. Oscar Health had a negative net margin of 2.16% and a negative return on equity of 21.50%. The company had revenue of $2.93 billion for the quarter, compared to analyst estimates of $3.09 billion. During the same period in the prior year, the business posted ($0.22) earnings per share. The firm’s revenue for the quarter was up 23.2% compared to the same quarter last year. On average, analysts forecast that Oscar Health, Inc. will post 0.69 EPS for the current year.

Insider Transactions at Oscar Health

In other Oscar Health news, insider Janet Liang sold 7,338 shares of the business’s stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total transaction of $121,737.42. Following the sale, the insider directly owned 172,527 shares in the company, valued at approximately $2,862,222.93. The trade was a 4.08% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Mario Schlosser sold 395,000 shares of the firm’s stock in a transaction on Monday, September 22nd. The shares were sold at an average price of $18.43, for a total value of $7,279,850.00. Following the completion of the transaction, the insider owned 501,148 shares of the company’s stock, valued at approximately $9,236,157.64. This represents a 44.08% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 739,472 shares of company stock valued at $12,616,880. Company insiders own 25.11% of the company’s stock.

Institutional Trading of Oscar Health

A number of hedge funds have recently bought and sold shares of the company. IFP Advisors Inc raised its holdings in Oscar Health by 2,762.6% in the 3rd quarter. IFP Advisors Inc now owns 6,498 shares of the company’s stock valued at $123,000 after acquiring an additional 6,271 shares during the last quarter. Cantor Fitzgerald L. P. lifted its position in Oscar Health by 2.2% during the third quarter. Cantor Fitzgerald L. P. now owns 125,144 shares of the company’s stock worth $2,369,000 after buying an additional 2,637 shares during the period. CIBC Bancorp USA Inc. purchased a new position in Oscar Health during the third quarter worth about $392,000. EMC Capital Management boosted its stake in Oscar Health by 336.7% in the 3rd quarter. EMC Capital Management now owns 13,100 shares of the company’s stock worth $248,000 after buying an additional 10,100 shares during the last quarter. Finally, Advisory Services Network LLC grew its holdings in Oscar Health by 390.1% in the 3rd quarter. Advisory Services Network LLC now owns 39,235 shares of the company’s stock valued at $743,000 after buying an additional 31,229 shares during the period. Institutional investors and hedge funds own 75.70% of the company’s stock.

About Oscar Health

(Get Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Further Reading